Klotz L - Search Results

1

Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.

Bruinsma SM, Roobol MJ, Carroll PR, Klotz L, Pickles T, Moore CM, Gnanapragasam VJ, Villers A, Rannikko A, Valdagni R, Frydenberg M, Kakehi Y, Filson CP, Bangma CH; Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. Bruinsma SM, et al. Among authors: klotz l. Nat Rev Urol. 2017 May;14(5):312-322. doi: 10.1038/nrurol.2017.26. Epub 2017 Mar 14. Nat Rev Urol. 2017. PMID: 28290462 Free article. Review.

2

Fertility status of patients with clinical stage I testis tumors on a surveillance protocol.

Carroll PR, Morse MJ, Whitmore WF Jr, Sogani PC, Klotz L, Herr HW, Fair WR, Feldshuh R, Chaganti RS. Carroll PR, et al. Among authors: klotz l. J Urol. 1987 Jul;138(1):70-2. doi: 10.1016/s0022-5347(17)42993-4. J Urol. 1987. PMID: 3599224

3

Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group.

Goldenberg SL, Klotz LH, Srigley J, Jewett MA, Mador D, Fradet Y, Barkin J, Chin J, Paquin JM, Bullock MJ, Laplante S. Goldenberg SL, et al. Among authors: klotz lh. J Urol. 1996 Sep;156(3):873-7. J Urol. 1996. PMID: 8709351 Clinical Trial.

4

Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis.

Nam RK, Fleshner N, Rakovitch E, Klotz L, Trachtenberg J, Choo R, Morton G, Danjoux C. Nam RK, et al. Among authors: klotz l. J Urol. 1999 May;161(5):1521-4. J Urol. 1999. PMID: 10210387

5

Differences between urologists in the United States and Canada in the approach to prostate cancer.

Fleshner N, Rakovitch E, Klotz L. Fleshner N, et al. Among authors: klotz l. J Urol. 2000 May;163(5):1461-6. J Urol. 2000. PMID: 10751858

6

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

Choo R, Klotz L, Danjoux C, Morton GC, DeBoer G, Szumacher E, Fleshner N, Bunting P, Hruby G. Choo R, et al. Among authors: klotz l. J Urol. 2002 Apr;167(4):1664-9. J Urol. 2002. PMID: 11912384

7

Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases.

Fleshner N, Klotz L. Fleshner N, et al. Among authors: klotz l. Urology. 2002 Jul;60(1):93-7. doi: 10.1016/s0090-4295(02)01625-4. Urology. 2002. PMID: 12100931

8

Expectant management with selective delayed intervention for favorable-risk prostate cancer.

Klotz LH, Choo R, Morton G, Danjoux C. Klotz LH, et al. Can J Urol. 2002 Jun;9 Suppl 1:2-7. Can J Urol. 2002. PMID: 12121587 Review.

9

Controversies in the management of localized prostate cancer: consensus development by Canadian urologists.

Klotz LH, Fradet Y. Klotz LH, et al. Can J Urol. 2002 Jun;9 Suppl 1:30-5. Can J Urol. 2002. PMID: 12121593 Review.

10

Results of a survey of Canadian men with prostate cancer.

Gray RE, Klotz LH, Iscoe NA, Fitch MI, Franssen E, Johnson BJ, Labrecque MM. Gray RE, et al. Can J Urol. 1997 Feb;4(2):359-365. Can J Urol. 1997. PMID: 12735852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,074 results

Search Page

Filters